600675.SS
600675.SS
CNE000000B42
CHINA ENTERPRISE COMPANY LIMITE
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 42/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.7x).

Beta (Market Relation)
0.71x
Defensive
Volatility (5Y p.a.)
40.5% p.a.
5-Year Horizon
Max Drawdown (5Y)
-55.7%
5-Year Horizon
Sharpe Ratio
-0.17
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -16.5%
3 Years 39.5% -55.5% -0.36 -11.7%
5 Years 40.5% -55.7% -0.17 -4.3%
10 Years 35.0% -70.4% -0.22 -5.3%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Strong cyclicality: The business model is sensitive to economic downturns.
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (40.5% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -70.4% in the extended horizon.
ende